Stadpharm
Stadpharm is a Malaysian pharmaceutical company, founded in 2003 and based in Petaling Jaya, that markets imported medicines in Malaysia and offers product registration and regulatory support services to pharmaceutical principals.
- Company typePrivate
- Founded2003
- HeadquartersPetaling Jaya, Malaysia
- Headcount11–50
- GTM typeB2B
- OfferingServices
Stadpharm firmographics
Firmographics- Name
- Stadpharm
- Website
- https://stadpharm.com.my
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Stadpharm is a Malaysian pharmaceutical company, founded in 2003 and based in Petaling Jaya, that markets imported medicines in Malaysia and offers product registration and regulatory support services to pharmaceutical principals.
- Ownership category
- akta.pro rank
Stadpharm industry classification
Industry- Product category
- Pharmaceutical Distribution & Regulatory Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industry
- Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)
Keywords
Where Stadpharm is headquartered
LocationHeadquarters
- HQ city
- Petaling Jaya
- HQ country
- Malaysia
- HQ region
- Asia
Markets served
Stadpharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Others
Stadpharm product offering
Product offeringCore offering
Stadpharm markets imported pharmaceutical medicines in Malaysia on behalf of foreign manufacturers and provides product registration and regulatory support services to help those manufacturers obtain and maintain Malaysian marketing authorization. The company acts as the local commercialization and regulatory affairs partner for international pharmaceutical principals targeting the Malaysian market.
Differentiator
Problem solved
Functional benefit
Products and services
- Imported Medicines Marketing Local marketing and distribution of imported pharmaceutical products in Malaysia on behalf of foreign manufacturers and principals, acting as the in-country commercialization partner.
- Pharmaceutical Product Registration Regulatory service assisting foreign pharmaceutical manufacturers with preparing and submitting product dossiers for registration with the Malaysian National Pharmaceutical Regulatory Agency (NPRA), including serving as the local marketing authorization holder.
- Regulatory Support Services Ongoing regulatory affairs support for registered pharmaceutical products in Malaysia, including license maintenance, variations, renewals, and post-registration compliance activities.
Companies that use Stadpharm
Customer profileIdeal customer profiles1 record
Stadpharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Stadpharm partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
Stadpharm competitors and assessment
Company assessmentDirect peers
- Hovid Berhad: Malaysia-based pharmaceutical company that develops, manufactures and markets generic and branded pharmaceutical products including imported lines, sharing Stadpharm's positioning at the intersection of regulatory, importation and marketing activities for pharmaceutical principals.
- Duopharma Biotech Berhad: Malaysian pharmaceutical company listed on Bursa Malaysia that manufactures, imports and distributes generic and ethical pharmaceutical products domestically, with compliance and registration capabilities comparable to those Stadpharm offers to foreign principals.
- Apex Healthcare Berhad: Malaysian pharma group that imports, distributes and markets pharmaceutical and consumer-health products through its Xiamen and Sterling subsidiaries, operating a model very similar to Stadpharm's imported-medicine marketing focus.
- Pharmaniaga Berhad: Malaysia's largest pharmaceutical distributor with a government-concession logistics business and a logistics & distribution division serving hospitals, clinics and retail pharmacies across the country; highly comparable as a domestic pharma wholesaler/import partner for foreign principals.
Broad incumbents
- Sime Darby Healthcare: Diversified Malaysian conglomerate with a healthcare arm that imports and distributes pharmaceutical and medical products in Malaysia, providing a benchmark for the scale and breadth a regional pharma distributor could reach in the same market as Stadpharm.
- DKSH Malaysia: DKSH's Healthcare business in Malaysia imports, registers and markets pharmaceutical and consumer health products for foreign manufacturers, providing both market entry/regulatory services and downstream distribution — a close functional analogue of Stadpharm's dual business model.
- Zuellig Pharma: One of the largest pharma distribution and marketing services platforms in Asia, headquartered in Singapore with deep Malaysian operations, providing importation, regulatory and commercialization services to multinational pharma — overlapping directly with Stadpharm's imported-medicine and registration mandate.
Regional players
- IDS Medical Systems (Malaysia): Asia-Pacific medical and pharmaceutical marketing/distribution group active in Malaysia that imports and registers specialty pharma on behalf of foreign manufacturers, competing for the same mandate of providing product entry plus ongoing commercialization in Malaysia.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Stadpharm social profiles
Digital presenceStadpharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stadpharm leadership team
Management profileNumber of profiles
Stadpharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stadpharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stadpharm
What does Stadpharm do?
Stadpharm markets imported pharmaceutical medicines in Malaysia on behalf of foreign manufacturers and provides product registration and regulatory support services to help those manufacturers obtain and maintain Malaysian marketing authorization. The company acts as the local commercialization and regulatory affairs partner for international pharmaceutical principals targeting the Malaysian market.
When was Stadpharm founded?
Stadpharm was founded in 2003. It employs 11 to 50 people.
Where is Stadpharm based?
Stadpharm is headquartered in Petaling Jaya, Malaysia, in the Asia region.
Who are Stadpharm's main competitors?
Direct peers on record are Hovid Berhad, Duopharma Biotech Berhad, Apex Healthcare Berhad and Pharmaniaga Berhad. Broad incumbents are Sime Darby Healthcare, DKSH Malaysia and Zuellig Pharma. IDS Medical Systems (Malaysia) is listed as a regional player.
Does Stadpharm have an API?
No public API is recorded for Stadpharm.
What industry is Stadpharm in?
Stadpharm's product category is Pharmaceutical Distribution & Regulatory Services. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAK, Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers. Its NAICS code is 424210 and its SIC code is 5122.